ERBB2 and metastatic malignant neoplasm in the lymph nodes: In a study examining the correlation between lymph node metastasis and clinicopathological features among 91,364 patients with T1 breast cancer using information from the “Surveillance, Epidemiology, and End Results Program (SEER)” study, age, race, primary site, tumor size, and ER, PgR, and HER2 status were influencing factors [38].